Daiichi Sankyo
Daiichi Sankyo, the largest pharmaceutical company in Japan, specializes in the production of prescription drugs. The company was founded in 2005 when Daiichi Pharmaceutical and Sankyo merged. Daiichi Sankyo merged to become Japan's largest pharmaceutical company.
Cardiovascular, bone and joint, autoimmune, metabolic, and infectious diseases are all areas where the company has a presence. Innovative pharmaceuticals, generics, vaccines, and over-the-counter (OTC) medicines are the company's four business units.
The company sells its entire portfolio in 44 different countries.
- Headquarters: Daiichi Sankyo Building A/B 3-5-1, Nihonbashi-honcho, Chūō-Ku, Tokyo 103-8426, Japan
- Founded: Tokyo, Japan (2005) (by merger)
- Revenue: $42.70 Billion (11/2021)
- Website: http://www.daiichisankyo.com
